Zobrazeno 1 - 10
of 1 558
pro vyhledávání: '"Del Giglio A"'
Autor:
Lucíola de Barros Pontes, Lessandra Chinaglia, Theodora Karnakis, Juliana Todaro, Heloisa Veasay Rodrigues, Polianna Mara Rodrigues de Souza, Ludmila de Ol iveira Koch, Rafael Aliosha Kaliks Guendelmann, Auro del Giglio
Publikováno v:
Geriatrics, Gerontology and Aging, Vol 11, Pp 76-79 (2024)
OBJECTIVE: To describe the translation and transcultural adaptation of Hurria's chemotherapy toxicity score, a prediction tool to estimate chemotherapy toxicity in the elderly. METHODS: The original English version of the score was translated to Port
Externí odkaz:
https://doaj.org/article/54cbd18edd0044dabae6a88a8461d7e6
Autor:
Marco Caminati, MD, Lucia Federica Carpagnano, MD, Chiara Alberti, MSc, Francesco Amaddeo, PhD, Riccardo Bixio, MD, Federico Caldart, MD, Lucia De Franceschi, PhD, Micol Del Giglio, PhD, Giuliana Festi, MD, Simonetta Friso, PhD, Luca Frulloni, MD, Paolo Gisondi, MD, Mauro Krampera, PhD, Giuseppe Lippi, PhD, Claudio Micheletto, MD, Giorgio Piacentini, PhD, Patrick Pinter, MD, Maurizio Rossini, PhD, Michele Schiappoli, MD, Cristina Tecchio, PhD, Laura Tenero, PhD, Elisa Tinazzi, PhD, Gianenrico Senna, MD, Matilde Carlucci, MD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100928- (2024)
Hypereosinophilic syndromes (HES) represent a group of rare dis-immune conditions characterized by blood hyper-eosinophilia and eosinophilic related burden. Especially the idiopathic subtype (I-HES) is particularly difficult to diagnose because of it
Externí odkaz:
https://doaj.org/article/dbbf5baf061344db9728a002cad44571
Autor:
Francesco Bellinato, Maria Marocchi, Luca Pecoraro, Marco Zaffanello, Micol Del Giglio, Giampiero Girolomoni, Giorgio Piacentini, Erika Rigotti
Publikováno v:
Children, Vol 11, Iss 11, p 1397 (2024)
Infantile haemangiomas (IHs) affect 3–10% of infants, 10% of whom need topical or systemic beta-blocker therapy. Propranolol is the first choice for IHs with a high risk of complications. Since more than half of IHs leave a permanent mark, to reduc
Externí odkaz:
https://doaj.org/article/32d88df697b54d508cbe9f0ce75eb951
Autor:
Caminati, Marco, Carpagnano, Lucia Federica, Alberti, Chiara, Amaddeo, Francesco, Bixio, Riccardo, Caldart, Federico, De Franceschi, Lucia, Del Giglio, Micol, Festi, Giuliana, Friso, Simonetta, Frulloni, Luca, Gisondi, Paolo, Krampera, Mauro, Lippi, Giuseppe, Micheletto, Claudio, Piacentini, Giorgio, Pinter, Patrick, Rossini, Maurizio, Schiappoli, Michele, Tecchio, Cristina, Tenero, Laura, Tinazzi, Elisa, Senna, Gianenrico, Carlucci, Matilde
Publikováno v:
In World Allergy Organization Journal August 2024 17(8)
Autor:
Fabre, B.L., Magalhaes Filho, M.A.F., Aguiar, P.N., Jr, da Costa, F.M., Gutierres, B., William, W.N., Jr, Del Giglio, A.
Publikováno v:
In ESMO Real World Data and Digital Oncology June 2024 4
Autor:
Carla Santos Rossi Paniquar, Auro del Giglio, Alayne Magalhães Trindade Domingues Yamada, Felipe José Silva Melo Cruz
Publikováno v:
O Mundo da Saúde, Vol 48 (2024)
To evaluate the role of pregabalin in the protection of chemotherapy-induced nausea and vomiting, we performed a phase II randomized, double-blind, placebo-controlled trial to investigate whether pregabalin could improve the complete control of nause
Externí odkaz:
https://doaj.org/article/05982a5d854e4a8b9bceba58c020e934
Autor:
Larissa Vieira de Queiroz, José Favoreto Neto, Fernando Luiz Affonso Fonseca, Carlos Cleomir Pinheiro, Auro del Giglio
Publikováno v:
Complementary Therapies in Medicine, Vol 80, Iss , Pp 103021- (2024)
Introduction: Zerumbone is a natural compound found in bitter ginger plants (Zingiber zerumbet) that shows antiproliferative, antioxidant, anti-inflammatory, and analgesic properties. We aimed to investigate the role of zerumbone in improving the qua
Externí odkaz:
https://doaj.org/article/b458caa2fdc04079b0b49d42952254ed
Autor:
Auro del Giglio, Beatriz da Costa Aguiar Alves, André Márcio Murad, Fernando Luiz Affonso Fonseca
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background The BRCA2 gene is a well-known tumor suppressor gene implicated in breast and ovarian cancers. BRCA1/2 mutations can be sensitive to poly ADP-ribose polymerase (PARP) inhibitors such as olaparib. However, some of these patients de
Externí odkaz:
https://doaj.org/article/245731edf7c244e2a9b39f524c011904
Autor:
Milena Brachmans Mascarenhas Neves, Yuri Costa Sarno Neves, Juliana Vieira Biason Bomonetto, Priscila Prais Carneiro Matos, Auro Del Giglio, Daniel de Iracema Gomes Cubero
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with cancer in the disease’s end-stage with poor performance represent a challenging clinical scenario, as they have high chance of a fatal outcome due to clinical conditions, oncological emergencies, and/or metastatic
Externí odkaz:
https://doaj.org/article/f95671062ae64c068ec5101f2c7737aa
Autor:
de Queiroz, Larissa Vieira, Neto, José Favoreto, Fonseca, Fernando Luiz Affonso, Pinheiro, Carlos Cleomir, del Giglio, Auro
Publikováno v:
In Complementary Therapies in Medicine March 2024 80